Transforming growth factor-β1, Th1 responses, and autoimmune liver disease

Transfusion

Volumn 45, Issue SUPPL. 2, 2005, Pages

  Gorham, James D ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 1ALPHA; LEUKOTRIENE; LYMPHOTOXIN; THROMBOCYTE CONCENTRATE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; TGFB1 PROTEIN, HUMAN; TGFB1 PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA;

ALLELE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BLOOD COMPONENT; CD4+ T LYMPHOCYTE; DENSITOMETRY; FLOW CYTOMETRY; IMMUNOBIOLOGY; IMMUNOREGULATION; INFLAMMATION; LIVER DISEASE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PHENOTYPE; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW; TH1 CELL; ANIMAL; BLOOD TRANSFUSION; HUMAN; IMMUNOLOGY; LIVER; MOUSE; PATHOLOGY; PHYSIOLOGY; SPECIES DIFFERENCE;

ANIMALS; AUTOIMMUNE DISEASES; BLOOD TRANSFUSION; HUMANS; LIVER; LIVER DISEASES; MICE; SPECIES SPECIFICITY; TH1 CELLS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 23844479613     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2005.00536.x     Document Type: Review

References (52)

1. Bonewald LF. Regulation and regulatory activities of transforming growth factor beta. Crit Rev Eukaryot Gene Expr 1999 9 : 33 44.
2. Piek E Roberts AB. Suppressor and oncogenic roles of transforming growth factor-beta and its signaling pathways in tumorigenesis. Adv Cancer Res 2001 83 : 1 54.
3. Hata A Shi Y Massague J. TGF-beta signaling and cancer: structural and functional consequences of mutations in Smads. Mol Med Today 1998 4 : 257 62.
4. Hocevar BA Howe PH. Mechanisms of TGF-beta-induced cell cycle arrest. Miner Electrolyte Metab 1998 24 : 131 5.
5. Herrera RE. The growth-inhibitory effects of TGF beta. Prog Mol Subcell Biol 1998 20 : 11 24.
6. O'Kane S Ferguson MW. Transforming growth factor betas and wound healing. Int J Biochem Cell Biol 1997 29 : 63 78.
7. Cheng J Grande JP. Transforming growth factor-beta signal transduction and progressive renal disease. Exp Biol Med 2002 227 : 943 56.
8. Gaedeke J Peters H Noble NA Border WA. Angiotensin II, TGF-beta and renal fibrosis. Contrib Nephrol 2001 135 : 153 60.
9. Roberts B Sporn MB. Transforming growth factors. Cancer Surv 1985 4 : 683 705.
10. Derynck R Jarrett JA Chen EY, et al. Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature 1985 316 : 701 5.
11. Shull MM Ormsby I Kier AB, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992 359 : 693 9.
12. Diebold RJ Eis MJ Yin M, et al. Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated. Proc Natl Acad Sci U S A 1995 92 : 12215 9.
13. Letterio JJ Geiser AG Kulkarni AB, et al. Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression. J Clin Invest 1996 98 : 2109 19.
14. Vamvakas EC. Possible mechanisms of allogeneic blood transfusion- associated postoperative infection. Transfus Med Rev 2002 16 : 144 60.
15. Blajchman MA. Immunomodulation and blood transfusion. Am J Ther 2002 9 : 389 95.
16. Josien R Douillard P Guillot C, et al. A critical role for transforming growth factor-beta in donor transfusion-induced allograft tolerance. J Clin Invest 1998 102 : 1920 6.
17. Assoian RK Komoriya A Meyers CA, et al. Transforming growth factor-beta in human platelets: identification of a major storage site, purification, and characterization. J Biol Chem 1983 258 : 7155 60.
18. Palmer DS Aye MT Dumont L, et al. Prevention of cytokine accumulation in platelets obtained with the COBE Spectra apheresis system. Vox Sang 1998 75 : 115 23.
19. Fujihara M Ikebuchi K Wakamoto S Sekiguchi S. Effects of filtration and gamma radiation on the accumulation of RANTES and transforming growth factor-beta1 in apheresis platelet concentrates during storage. Transfusion 1999 39 : 498 505.
20. Wadhwa M Seghatchian MJ Dilger P, et al. Cytokines in WBC-reduced apheresis PCs during storage: a comparison of two WBC-reduction methods. Transfusion 2000 40 : 1118 26.
21. Dzik S Mincheff M Puppo F. Apoptosis, transforming growth factor-beta, and the immunosuppressive effect of transfusion. Transfusion 2002 42 : 1221 3.
22. Kunz D Luley C Heim MU Bock M. Transforming growth factor beta is increased in plasma of patients with hematologic malignancies after transfusion of platelet concentrates. Transfusion 1998 38 : 156 9.
23. Gafter U Kalechman Y Sredni B. Blood transfusion enhances production of T helper-2 cytokines and transforming growth factor beta in humans. Clin Sci 1996 91 : 519 23.
24. Murphy KM Reiner SL. The lineage decisions of helper T cells. Nat Rev Immunol 2002 2 : 933 44.
25. Swain SL Huston G Tonkonogy S Weinberg AD. Transforming growth factor-beta and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J Immunol 1991 147 : 2991 3000.
26. Hoehn P Goedert S Germann T, et al. Opposing effects of TGF-beta 2 on the Th1 cell development of naive CD4+ T cells isolated from different mouse strains. J Immunol 1995 155 : 3788 93.
27. Schmitt E Hoehn P Huels C, et al. T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-gamma and is inhibited by transforming growth factor-beta. Eur J Immunol 1994 24 : 793 8.
28. Lingnau K Hoehn P Kerdine S, et al. IL-4 in combination with TGF-beta favors an alternative pathway of Th1 development independent of IL-12. J Immunol 1998 161 : 4709 18.
29. Gorham JD Güler ML Fenoglio D, et al. Low dose TGF-beta attenuates IL-12 responsiveness in murine Th cells. J Immunol 1998 161 : 1664 70.
30. Güler ML Gorham JD Hsieh CS, et al. Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development. Science 1996 271 : 984 7.
31. Güler ML Jacobson NG Gubler U Murphy KM. T cell genetic background determines maintenance of IL-12 signaling: effects on BALB/c and B10.D2 T helper cell type 1 phenotype development. J Immunol 1997 159 : 1767 74.
32. Bonyadi M Rusholme SA Cousins FM, et al. Mapping of a major genetic modifier of embryonic lethality in TGF beta 1 knockout mice. Nat Genet 1997 15 : 207 11.
33. Boivin GP O'Toole BA Orsmby IE, et al. Onset and progression of pathological lesions in transforming growth factor-beta 1-deficient mice. Am J Pathol 1995 146 : 276 88.
34. Kulkarni B Ward JM Yaswen L, et al. Transforming growth factor-beta 1 null mice: an animal model for inflammatory disorders. Am J Pathol 1995 146 : 264 75.
35. Williams O Knapton AD Geiser A, et al. The liver in transforming growth factor-beta-1 (TGF-beta 1) null mutant mice. Ultrastruct Pathol 1996 20 : 477 90.
36. Gorham JD Lin JT Sung JL, et al. Genetic regulation of autoimmune disease: BALB/c background TGF-beta 1-deficient mice develop necroinflammatory IFN-gamma-dependent hepatitis. J Immunol 2001 166 : 6413 22.
37. + T cells. J Immunol 2003 170 : 4785 92.
38. Mehal WZ Azzaroli F Crispe IN. Antigen presentation by liver cells controls intrahepatic T cell trapping, whereas bone marrow-derived cells preferentially promote intrahepatic T cell apoptosis. J Immunol 2001 167 : 667 73.
39. Mehal WZ Juedes AE Crispe IN. Selective retention of activated CD8+ T cells by the normal liver. J Immunol 1999 163 : 3202 10.
40. Ogasawara J Watanabe-Fukunaga R Adachi M, et al. Lethal effect of the anti-Fas antibody in mice. Nature 1993 364 : 806 9.
41. Schlosser SF Azzaroli F Dao T, et al. Induction of murine hepatocyte death by membrane-bound CD95 (Fas/APO-1)-ligand: characterization of an in vitro system. Hepatology 2000 32 : 779 85.
42. lo thymocytes in vivo. Science 1990 250 : 1720 3.
43. Gorham JD Güler ML Steen RG, et al. Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses. Proc Natl Acad Sci U S A 1996 93 : 12467 72.
44. Czaja J Donaldson PT. Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis. Immunol Rev 2000 174 : 250 9.
45. Donaldson PT. Genetics in autoimmune hepatitis. Semin Liver Dis 2002 22 : 353 64.
46. Mackay R Morris PJ. Association of autoimmune active chronic hepatitis with HLA-A1,8. Lancet 1972 2 : 793 5.
47. Wicker LS Appel MC Dotta F, et al. Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice: the NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes. J Exp Med 1992 176 : 67 77.
48. Encinas JA Kuchroo VK. Mapping and identification of autoimmunity genes. Curr Opin Immunol 2000 12 : 691 7.
49. Kono DH Theofilopoulos AN. Genetics of systemic autoimmunity in mouse models of lupus. Int Rev Immunol 2000 19 : 367 87.
50. Lin JT Kitzmiller TJ Cates JM Gorham JD. MHC-independent genetic regulation of liver damage in a mouse model of autoimmune hepatocellular injury. Lab Invest 2005 85 : 550 61.
51. Nelson DR Lau JY. Pathogenesis of hepatocellular damage in chronic hepatitis C virus infection. Clin Liver Dis 1997 1 : 515 28.
52. Rosen HR. Hepatitis C pathogenesis: mechanisms of viral clearance and liver injury. Liver Transplant 2003 9 : S35 3.